The Office of the Community Liaison, Business Students for Racial Equity & Health Care, and Life Sciences Club Presents: Ozempic, Wegovy, Mounjaro: What are the implications of the new obesity and diabetes drugs for health and health equity?

A conversation about the healthcare marketplace, health equity, and innovation.
With Mark Abraham of DataHaven, Lou Hart, MD Assistant Professor of Pediatrics (Hospital Medicine); Medical Director of Health Equity, Yale New Haven Health System, EMBA ‘25 and Ania Jastreboff, MD, PhD
Associate Professor of Medicine (Endocrinology); Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management.